SCHEMBL27469327

SCHEMBL27469327

CSCc1ccc2nccc(O)c2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC22A12 Q96S37 5/20 0.39
NOS3 P29474 1/20 0.35
NOS1 P29475 1/20 0.35
NOS2 P35228 1/20 0.35
MIF P14174 1/20 0.34
HTR1A P08908 2/20 0.33
ADRA1D P25100 2/20 0.33
ADRA1A P35348 2/20 0.33
ADRA1B P35368 2/20 0.33
CYP1A2 P05177 2/20 0.33
CYP19A1 P11511 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
ALOX15 P16050 1/20 0.32
CASP1 P29466 1/20 0.32
CASP7 P55210 1/20 0.32
HSD17B10 Q99714 1/20 0.32
MAPKAPK2 P49137 1/20 0.32
MTNR1A P48039 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10657341 0.81 TRPA1 (0.47) SLC22A12NOS3NOS1NOS2SMN1; SMN2
SCHEMBL27469333 0.81 DYRK1B (0.38) SLC22A12NOS3NOS1NOS2HTR1A
SCHEMBL30979490 0.81 DYRK1B (0.38) SLC22A12NOS3NOS1NOS2HTR1A
SCHEMBL2588801 0.75 SMN1; SMN2 (0.44) SLC22A12CYP1A2SMN1; SMN2HSD17B10MAPKAPK2
SCHEMBL24368246 0.74 KDM4E (0.51) SLC22A12HSD17B10LMNA
SCHEMBL3862227 0.74 IDH1 (0.51) SLC22A12CDK8
SCHEMBL27907349 0.74 SLC22A12 (0.39) SLC22A12HTR1AADRA1DADRA1AADRA1B
SCHEMBL16247960 0.72 SLC22A12 (0.56) SLC22A12CYP19A1MAPKAPK2AKT1PIK3CA
SCHEMBL21465994 0.72 NOS3 (0.41) NOS3NOS1NOS2MIFCYP1A2
SCHEMBL5539379 0.72 HTR1A (0.54) SLC22A12NOS3NOS1NOS2HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024112854-A1 INHIBITORS OF RIPK2 AND MEDICAL USES THEREOF ODYSSEY THERAPEUTICS, INC. (US) 2024-05-30 WO disclosed